These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22614002)

  • 1. False positive drugs of abuse immunoassays.
    Kapur BM
    Clin Biochem; 2012 Jun; 45(9):603-4. PubMed ID: 22614002
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor regarding a report about the potential for commonly used baby cleansers to interfere with cannabinoid (THC) immunoassays.
    Mays DA; McCarthy TJ
    Clin Biochem; 2012 Oct; 45(15):1266; author reply 1267. PubMed ID: 22884487
    [No Abstract]   [Full Text] [Related]  

  • 3. Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay.
    Cotten SW; Duncan DL; Burch EA; Seashore CJ; Hammett-Stabler CA
    Clin Biochem; 2012 Jun; 45(9):605-9. PubMed ID: 22465236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine.
    Rossi S; Yaksh T; Bentley H; van den Brande G; Grant I; Ellis R
    Clin Chem; 2006 May; 52(5):896-7. PubMed ID: 16638958
    [No Abstract]   [Full Text] [Related]  

  • 5. Interpretation and utility of drug of abuse immunoassays: lessons from laboratory drug testing surveys.
    Melanson SE; Baskin L; Magnani B; Kwong TC; Dizon A; Wu AH
    Arch Pathol Lab Med; 2010 May; 134(5):735-9. PubMed ID: 20441504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Substances of abuse in urine samples].
    Mørland J
    Tidsskr Nor Laegeforen; 2011 Mar; 131(6):560. PubMed ID: 21423299
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of adulterants on urine screen for drugs of abuse: detection by an on-site dipstick device.
    Wong R
    Am Clin Lab; 2002; 21(1):37-9. PubMed ID: 11975450
    [No Abstract]   [Full Text] [Related]  

  • 8. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of the metabolite of delta-9-tetrahydrocannabinol in urine by means of GC/MS and interpretation of analytical findings].
    Balíková M; Maresová V
    Soud Lek; 1996 Dec; 41(4):36-40. PubMed ID: 16841441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Do urine tests for drugs of abuse cover the substances of interest?].
    Dyrkorn R; Reimers A; Johannessen L; Spigset O
    Tidsskr Nor Laegeforen; 2011 Mar; 131(6):570-2. PubMed ID: 21423307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoassay methods used to diagnose patients poisoned with psychoactive substances--analytical and interpretation problems].
    Gomółka E; Hydzik P; Madej T; Łata S; Rojek S
    Przegl Lek; 2012; 69(8):629-31. PubMed ID: 23243950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse.
    Beck O; Rausberg L; Al-Saffar Y; Villen T; Karlsson L; Hansson T; Helander A
    Drug Test Anal; 2014 May; 6(5):492-9. PubMed ID: 24665024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efavirenz interference in urine screening immunoassays for tetrahydrocannabinol.
    Oosthuizen NM; Laurens JB
    Ann Clin Biochem; 2012 Mar; 49(Pt 2):194-6. PubMed ID: 22067092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-positive interferences of common urine drug screen immunoassays: a review.
    Saitman A; Park HD; Fitzgerald RL
    J Anal Toxicol; 2014 Sep; 38(7):387-96. PubMed ID: 24986836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?
    Schaefer N; Helfer AG; Kettner M; Laschke MW; Schlote J; Ewald AH; Meyer MR; Menger MD; Maurer HH; Schmidt PH
    Drug Test Anal; 2017 Apr; 9(4):613-625. PubMed ID: 27328899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of KIMS immunoassays on a cobas c 501 analyzer for drugs of abuse and ethyl glucuronide testing in urine for forensic abstinence control.
    Neukamm MA; Bahrami A; Auwärter V; Mehne FMP; Höss E
    Drug Test Anal; 2017 Aug; 9(8):1217-1223. PubMed ID: 28024169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users.
    Lewis J; Molnar A; Allsop D; Copeland J; Fu S
    Int J Legal Med; 2016 Jan; 130(1):147-52. PubMed ID: 26233612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the urine drug screen in psychiatry emergency service 2.
    Akosile W; McDermott BM
    Australas Psychiatry; 2015 Dec; 23(6):710. PubMed ID: 26627350
    [No Abstract]   [Full Text] [Related]  

  • 19. [Detection of psychotropic drug abuse].
    Hainaut B; Noirfalise A
    Acta Med Leg Soc (Liege); 1989; 39(1):429-42. PubMed ID: 2520726
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of psychoactive drug testing in acute mental health services.
    Paton MB; Large MM
    Australas Psychiatry; 2015 Dec; 23(6):710-1. PubMed ID: 26627351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.